UK Markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
434.13-3.26 (-0.75%)
At close: 04:05PM EST
434.13 0.00 (0.00%)
After hours: 06:03PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3475.35
52-week low 3253.86
50-day moving average 3424.76
200-day moving average 3372.68

Share statistics

Avg vol (3-month) 3378.86k
Avg vol (10-day) 3431.36k
Shares outstanding 573.82M
Implied shares outstanding 6N/A
Float 873.49M
% held by insiders 10.64%
% held by institutions 195.94%
Shares short (14 Sept 2021) 4787.25k
Short ratio (14 Sept 2021) 42.51
Short % of float (14 Sept 2021) 41.21%
Short % of shares outstanding (14 Sept 2021) 41.06%
Shares short (prior month 12 Aug 2021) 41.06M

Dividends & splits

Forward annual dividend rate 40.68
Forward annual dividend yield 40.15%
Trailing annual dividend rate 30.66
Trailing annual dividend yield 30.15%
5-year average dividend yield 40.44
Payout ratio 49.78%
Dividend date 316 Nov 2021
Ex-dividend date 419 Jul 2021
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 20.58%
Operating margin (ttm)24.47%

Management effectiveness

Return on assets (ttm)14.49%
Return on equity (ttm)28.54%

Income statement

Revenue (ttm)2.52B
Revenue per share (ttm)34.09
Quarterly revenue growth (yoy)37.30%
Gross profit (ttm)767.8M
Net income avi to common (ttm)519.2M
Diluted EPS (ttm)5.57
Quarterly earnings growth (yoy)105.40%

Balance sheet

Total cash (mrq)576.2M
Total cash per share (mrq)7.79
Total debt (mrq)319.4M
Total debt/equity (mrq)15.71
Current ratio (mrq)3.12
Book value per share (mrq)24.78

Cash flow statement

Operating cash flow (ttm)500.4M
Levered free cash flow (ttm)176.91M